Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Colonic Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Lung Neoplasms; Melanoma; Mesothelioma; Small Cell Lung Carcinoma; Triple Negative Breast Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Neoplasms, Basal Cell; Skin Neoplasms; Squamous Cell Carcinoma of Head and Neck | Phase 2 | ClinicalTrials |
| Melanoma; Recurrence | Phase 2 | ClinicalTrials |
| Acute Lung Injury; Respiratory Distress Syndrome, Adult; Respiratory Distress Syndrome, Newborn; Smallpox | Phase 1 | ClinicalTrials |
| Lymphoma; Lymphoma, T-Cell | Phase 1 | ClinicalTrials |
| Glioblastoma | Phase 1 | ClinicalTrials |
| Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Breast Neoplasms | Phase 1 | ClinicalTrials |
| Astrocytoma; Glioma; Oligodendroglioma | Phase 1 | ClinicalTrials |
| Communicable Diseases; Infection | Phase 1 | ClinicalTrials |
| Melanoma | Phase 1 | ClinicalTrials |
| Lymphoma; Lymphoma, B-Cell | Phase 1/Phase 2 | ClinicalTrials |
| Astrocytoma; Glioblastoma | Phase 1 | ClinicalTrials |
| Adenocarcinoma | Phase 1 | ClinicalTrials |
| Neoplasms | Phase 1 | ClinicalTrials |
CONTENTS